SUMMARY Cefuroxime, a new antibiotic derived from cephalosporin-C which is very stable in the presence of r-lactamases produced by Gram-negative organisms, was used to treat 856 male patients and 340 female patients with uncomplicated gonorrhoea. In men the drug was used in three different doses, 1*5 g, 1 g, and 750 mg plus 1 g probenecid; in women 1 g and 750 mg cefuroxime plus 1 g probenecid was used. Cure rates ranged from 94-8 % to 99 3 %. The antibiotic was well tolerated and was free from side effects. Cefuroxime would be a valuable and efficient substitute for penicillin in the treatment of gonorrhoea due to 3-lactamase-producing strains of gonococci.
Introduction
Cefuroxime is a new antibiotic derived from cephalosporin-C, which is very active against the gonococcus in vitro-much more so than earlier cephalosporins-and is very stable in the presence of r-lactamases produced by Gram-negative or- ganisms. This latter property is of particular interest in view of the recent appearance of P-lactamaseproducing strains of gonococci (Phillips, 1976; Ashford et al, 1976) and warranted a clinical trial of cefuroxime in patients with gonorrhoea to see if this antibiotic is as active against the gonococcus in vivo as in vitro.
Materials and methods

STUDY POPULATION
Eight hundred and fifty-six male patients and 340 female patients with uncomplicated gonorrhoea were included in the trial. Patients who were pregnant, sensitive to cephalosporins, or under treatment with drugs for other complaints were excluded; otherwise the cases were unselected. Age Cefuroxime was injected intramuscularly and was given before the culture results were known if the microscopical evidence indicated gonorrhoea. Patients were asked to return for follow-up examina-tion within two to three days and then at intervals of one, two, four, and six weeks.
Male patients were asked to avoid alcohol and sexual intercourse for at least two weeks after apparent cure and to refrain from micturition for at least two hours before examination. Female patients were asked to avoid alcohol and sexual intercourse until two consecutive follow-up tests for gonococci gave negative results.
At the initial follow-up visit any urethral discharge in male patients was examined by smears and cultures. If there was no obvious discharge, smears and cultures were made from urethral scrapings. At subsequent visits specimens for bacteriological examination were not taken unless the history, clinical examination, or macroscopic appearance of the urine suggested that urethritis was still present.
In female patients, smears and culture specimens were taken from the urethra and cervix at each visit. Culture specimens were also taken from the pharynx and rectum if gonococci had been isolated previously from these sites.
Results
The number of patients who attended for each follow-up examination and the number of patients with positive results to tests for gonococci at these visits are shown in Tables 1-5. Cultures gave positive results for every patient from whom gonococci were recovered at the first or second follow-up visits. There was a history of exposure to fresh infection for every patient shown in the tables as a 'reinfection'. Table 6 gives our assessment of the cure rates obtained with the different regimens; there are two rates for each treatment. With both rates, patients with positive results to tests for gonorrhoea at the initial follow-up visit were classified as treatment failures, and patients in whom the gonococcal infection cleared with treatment and then recurred more than 14 days later were classified as having been successfully treated and reinfected. The other patients, those with negative results to tests at the first follow-up visit and positive results at the second, were assessed in two ways:
1. All patients were regarded as treatment failures. 2. Patients were regarded as treatment failures if there was no history of fresh exposure to infection and as having been reinfected if there was such a history. The first of these assessments was made in the light of the thesis by Willcox (1964) that all such cases could be relapses and the second in accordance with the criterion adopted by Lynn et al (1970) . The true rate of cure falls somewhere between the two rates given in Table 6 . The drug was well tolerated and remarkably free from side effects. Because of its stability in the presence of P-lactamases cefuroxime will be a valuable and efficient substitute for penicillin in the treatment of gonorrhoea due to P-lactamase-producing strains of gonococci. 
